Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

Vaccine

Volumn 16, Issue 5, 1998, Pages 439-445

  Hanke, T ^a   Blanchard, T J ^b   Schneider, J ^a   Hannan, C M ^a   Becker, M ^b   Gilbert, S C ^c   Hill, A V S ^a   Smith, G L ^b   McMichael, A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CTL; DNA; HIV; MVA; Polyepitope; Vaccine

Indexed keywords

DNA VACCINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VACCINIA VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA, VIRAL; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION, SECONDARY; INTERFERON INDUCERS; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VACCINIA VIRUS; VIRAL VACCINES;

EID: 0032033577     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00226-0     Document Type: Article

References (24)

1. 1 Zinkernagel, R.M. and Doherty, P.C. H-2 compatibility requirement for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J. Exp. Med. 1975, 141, 1427-1436.
2. 2 Kaegi, D. and Hengartnet, H. Different role of cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 1996, 8, 472-477.
3. 3 Hanke, T., Schneider, J., Gilbert, S.G., Hill, A.V.S. and McMichael, A. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice. Vaccine 1998, 16, 426-435.
4. 4 Davis, H.L., Schirmbeck, R., Reimann, J. and Whalen, R.G. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum. Gene Ther. 1995, 6, 1447-1456.
5. 5 Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. U.S.A. 1993, 90, 11478-11482.
6. + T lymphocytes. J. Immunol. 1995, 155, 259-265.
7. 7 Tang, D.C., DeVit, M. and Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154.
8. 8 Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L. and Dwarki, V.J. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
9. 9 Watanabe, A., Raz, E., Kohsaka, H., Tighe, H., Baird, S.M. and Kipps, T.J. et al. Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 1993, 151, 2871-2876.
10. 10 Whalen, R.G., Leclerc, C., Deriaud, E., Schirmbeck, R., Reimann, J. and Davis, H.L. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann. N. Y. Acad. Sci. 1995, 772, 64-76.
11. 11 Mayr, A., Hochstein-Mintzel, V. and Stickl, H. Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 1975, 105, 6-14.
12. 12 Altenburger, W., Suter, C.P. and Altenburger, J. Partial deletion of the human host range gene in the attenuated vaccinia virus MVA. Arch. Virol. 1989, 105, 15-27.
13. 13 Meyer, H., Sutler, G. and Mayr, A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 1991, 72, 1031-1038.
14. 14 Sutter, G. and Moss, B. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl Acad. Sci. U.S.A. 1992, 89, 10847-10851.
15. 15 Mayr, A., Stickl, H., Muller, H.K., Danner, K. and Singer, H. Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwachten Organismus. Zentralbl. Bakt. Hyg. I. (Abt. Orig. B). 1978, 167, 375-390.
16. 16 Gilbert, S.G., Plebanski, M., Harris, S.J., Allsopp, C.E.M., Thomas, R., Layton, G.T. and Hill, A.V.S. A protein particle vaccine containing multiple malaria epitope. Nature Biotechnol. 1997, in press.
17. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 1993, 5, 849-857.
18. 18 Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, R.S., Nussenzweig, V. and Zavala, F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341, 323-326.
19. 19 Miyahira, Y., Murata, K., Rodriguez, D., Rodriguez, J.R., Esteban, M., Rodrigues, M.M. and Zavala, F. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods 1995, 181, 45-54.
20. 20 Lalvani, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V. S. and McMichael, A. J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 1997, 186, 1-7.
21. 21 Lu, S., Santoro, J.C., Fuller, D.H., Haynes, J.R. and Robinson, H.L. Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 1995, 209, 147-154.
22. 22 Fuller, D.H., Murphy-Corb, M., Barnett, S., Steimer, K. and Haynes, J.R. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 1997, 15, 924-926.
23. 23 Letvin, N.L., Montefiori, D.C., Yasutomi, Y., Perry, H.C., Davies, M.-E. and Lekutis, C. et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl Acad. Sci. U.S.A. 1997, 94, 9378-9383.
24. 24 Barnett, S.W., Rajasekar, S., Legg, H., Doe, B., Fuller, D.H. and Haynes, J.R. et al. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 subunit. Vaccine 1997, 15, 869-973.